Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy

Drug Discovery Today
Lawrence R Dick, Paul Fleming

Abstract

Inhibition of the proteasome (a highly abundant enzymatic complex responsible for intracellular protein turnover) is an effective anti-cancer therapeutic approach, as demonstrated by the first-in-class agent bortezomib. Various new proteasome inhibitors are now in development, including peptide boronic acid analogs MLN9708 and CEP-18770, peptide epoxyketones carfilzomib and PR-047, and NPI-0052, a beta-lactone compound. All are potent inhibitors of proteasome activity in vitro but show differences in enzyme binding kinetics, which might affect their pharmacology and result in different efficacy and safety profiles. Here, we review the second-generation proteasome inhibitors and assess the potential pharmacologic impact of their different chemical properties.

Citations

Oct 16, 2012·Current Hematologic Malignancy Reports·Panisinee LawasutPaul G Richardson
Sep 18, 2012·Journal of Medicinal Chemistry·Andrew J Kale, Bradley S Moore
Apr 4, 2013·Journal of Medicinal Chemistry·Sevil OzcanSaïd M Sebti
Dec 15, 2010·Nature Reviews. Drug Discovery·Lynn BedfordJames E Brownell
Jul 5, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dharminder ChauhanKenneth C Anderson
Sep 10, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edmund C LeeSiegfried Janz
Jan 5, 2012·PloS One·Erika SuzukiChristopher J Kirk
Feb 7, 2013·Biologics : Targets & Therapy·Ajay NookaSagar Lonial
Nov 17, 2011·Drugs·Julie E Chang, Brad S Kahl
Apr 10, 2014·Molecular Medicine Reports·Bingpeng ChenJincheng Wang
Apr 27, 2013·Future Medicinal Chemistry·Bhaskar C DasTodd Evans
May 30, 2013·American Journal of Respiratory and Critical Care Medicine·Nathaniel M WeathingtonRama K Mallampalli
Jun 4, 2014·Critical Reviews in Oncology/hematology·Zdeněk Škrott, Boris Cvek
Aug 19, 2014·Antioxidants & Redox Signaling·Oliver Drews, Heinrich Taegtmeyer
Jan 21, 2014·Antioxidants & Redox Signaling·Silke MeinersAnne Caniard
Apr 30, 2014·American Journal of Respiratory Cell and Molecular Biology·Anke-Gabriele LenzOtmar Schmid
Sep 10, 2011·Natural Product Reports·Daniel KrahnMarkus Kaiser
Aug 30, 2013·Organic & Biomolecular Chemistry·Shuhei KawamuraSatoshi Shuto
Feb 2, 2012·Chemical Society Reviews·Christian OttmannMarkus Kaiser
Dec 24, 2013·Leukemia & Lymphoma·Sajjad HaiderJames J Driscoll
Feb 7, 2016·Bioorganic & Medicinal Chemistry Letters·Enrico MoreraLuciano De Petrocellis
Jan 24, 2014·Expert Opinion on Therapeutic Patents·Rainer MetcalfQ Ping Dou
Mar 13, 2013·Expert Review of Anticancer Therapy·Ali McBride, Patricia Y Ryan
Aug 28, 2012·Expert Opinion on Emerging Drugs·Massimo GentileFortunato Morabito
Oct 23, 2015·Critical Reviews in Oncology/hematology·Matthieu Cornelis Johannes BosmanEdo Vellenga
Aug 9, 2015·Biochimie·Isabelle LamsoulPierre G Lutz
Jul 1, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Suresh S RamalingamDavid R Gandara
Jan 29, 2016·Nature Cell Biology·Jon M Huibregtse, Andreas Matouschek
Feb 18, 2012·Kidney International·R Carlin WalshE Steve Woodle
Jun 26, 2012·Seminars in Hematology·Dixie-Lee Esseltine, George Mulligan
Jun 26, 2012·Seminars in Hematology·Christopher J Kirk
Jan 21, 2012·Actas dermo-sifiliográficas·R M MartíA Yeramian
Nov 13, 2014·Translational Oncology·Izabela Mlynarczuk-BialyPeter-M Kloetzel
May 6, 2015·Journal of the American Chemical Society·Naifu HuWenjun Tang
Jan 15, 2011·Trends in Cell Biology·Steven D Mason, Johanna A Joyce

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.